Want to see FR:SAVE full AI Analyst Report?
SAVE Stock Chart & Stats
€62.00
-€0.20(-0.39%)
At close: 4:00 PM EST
€62.00
-€0.20(-0.39%)
Day’s Range― - ―
52-Week Range€56.80 - €74.40
Previous CloseN/A
Volume51.00
Average Volume (3M)1.01K
Market Cap
€896.96M
Enterprise Value€1.62B
Total Cash (Recent Filing)€684.84M
Total Debt (Recent Filing)€1.24B
Price to Earnings (P/E)11.4
Beta0.25
Next Earnings
Sep 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.73%
Share Statistics
EPS (TTM)5.73
Shares Outstanding14,032,930
10 Day Avg. Volume636
30 Day Avg. Volume1,015
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)0.52
Price to Sales (P/S)0.13
P/FCF Ratio14.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€79.00Price Target Upside27.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)10.03
Revenue Forecast (FY)€7.22B
Bulls Say, Bears Say
Bulls Say
Diversified Business Routes (consumer + Professional)Dual revenue routes (branded retail and specialty professional sales) create durable demand diversification. This structural mix smooths cycle exposure, supports stable volumes across channels, and allows the group to leverage manufacturing and R&D across higher-margin specialty lines over the medium term.
Stable Gross Margins (~33–34%)Consistently robust gross margins indicate product mix strength and manufacturing efficiency. A steady gross margin provides a persistent buffer against commodity input swings, enabling the company to protect gross profitability and prioritize margin recovery measures when retail or input cost pressures persist.
Manageable Leverage And Stable Equity BaseDebt-to-equity near industry-appropriate levels gives financial flexibility for capex or targeted M&A without excessive refinancing risk. A stable equity base and moderate leverage support resilience versus shocks and allow the company to sustain investments in brands and production capacity across a 2–6 month horizon and beyond.
Bears Say
Declining Revenue In 2025A falling top line erodes scale advantages and may signal weakening product demand or pricing pressure. Persistent revenue contraction can amplify margin pressure, reduce bargaining power with retailers, and constrain reinvestment capacity, making recovery more difficult without structural product or channel shifts.
Margin Compression And Very Thin Net MarginCompressed operating margins and a sub-2% net margin leave little room to absorb commodity, energy, or logistics shocks. Sustained thin profitability limits retained earnings and reduces strategic flexibility for pricing, marketing, or capex, increasing vulnerability to sector cost swings over months to quarters.
Weakened Cash Conversion; Low FCF CoverageMaterial deterioration in cash conversion reduces capacity to self-fund investments, pay down debt, or maintain dividends. Low FCF relative to earnings constrains strategic optionality and heightens refinancing or payout risk if margins stay depressed or working capital needs rise over the medium term.
Savencia News
SAVE FAQ
What was Savencia SA’s price range in the past 12 months?
Savencia SA lowest stock price was €56.80 and its highest was €74.40 in the past 12 months.
What is Savencia SA’s market cap?
Savencia SA’s market cap is €896.96M.
When is Savencia SA’s upcoming earnings report date?
Savencia SA’s upcoming earnings report date is Sep 10, 2026 which is in 59 days.
How were Savencia SA’s earnings last quarter?
Savencia SA released its earnings results on Mar 05, 2026. The company reported €2.798 earnings per share for the quarter, beating the consensus estimate of N/A by €2.798.
Is Savencia SA overvalued?
According to Wall Street analysts Savencia SA’s price is currently Undervalued.
Does Savencia SA pay dividends?
Savencia SA pays a Annually dividend of €1.4 which represents an annual dividend yield of 2.73%. See more information on Savencia SA dividends here
What is Savencia SA’s EPS estimate?
Savencia SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Savencia SA have?
Savencia SA has 14,032,930 shares outstanding.
What happened to Savencia SA’s price movement after its last earnings report?
Savencia SA reported an EPS of €2.798 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.339%.
Which hedge fund is a major shareholder of Savencia SA?
Currently, no hedge funds are holding shares in FR:SAVE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Savencia SA
Savencia SA is a French-headquartered enterprise, established in 1956, specializing in the production of dairy items for both domestic and international markets. The company's product portfolio encompasses a diverse range of cheeses, along with butters and creams supplied to consumer retail outlets and professional catering services. Additionally, it furnishes dairy ingredients for the food, nutrition, and healthcare sectors. Known as Bongrain SA until its rebranding in April 2015, the firm now operates under the name Savencia SA and is based in Viroflay, France.
SAVE Stock 12 Month Forecast
Average Price Target
€79.00
▲(27.42% Upside)
Technical Analysis
Bonduelle
―
DANONE SA
―
Fleury Michon
―
Societe LDC Societe Anonyme
―
Saint Jean Groupe SA
―
Options Prices
Currently, No data available
---

